TABLE 2.
Spearman correlation analysis of the DGLA:DCAS ratio with metabolic markers in human and animal studies
| Human study |
Animal study |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Case-control study | R | P | MS | R | P | Serum | R | P | Liver | R | P |
| BMI | 0.37 | 2.80E-12 | BMI | 0.46 | 1.09E-03 | Body weight | 0.73 | 1.31E-03 | Body weight | 0.87 | 2.46E-04 |
| Glu | 0.33 | 1.62E-07 | TG | 0.44 | 1.79E-03 | Liver weight | 0.71 | 1.98E-03 | Liver weight | 0.81 | 1.36E-03 |
| TC | 0.22 | 1.11E-04 | TC | 0.25 | 8.12E-02 | VAT | 0.72 | 1.75E-03 | VAT | 0.85 | 5.21E-04 |
| TG | 0.33 | 4.07E-09 | HDL-C | −0.31 | 3.02E-02 | TG | 0.74 | 1.09E-03 | TG | 0.66 | 1.96E-02 |
| ALT | −0.02 | 6.65E-01 | LDL-C | 0.20 | 1.76E-01 | TC | 0.77 | 5.51E-04 | TC | 0.80 | 1.84E-03 |
| AST | 0.07 | 2.43E-01 | FPG | 0.25 | 8.07E-02 | HDL-C | 0.83 | 7.32E-05 | HDL-C | 0.89 | 1.14E-04 |
| γ-GGT | 0.45 | 1.68E-17 | 2hPG | 0.27 | 6.38E-02 | LDL-C | 0.75 | 8.78E-04 | LDL-C | 0.68 | 1.58E-02 |
| FIns | 0.35 | 1.50E-02 | FFA | 0.66 | 5.70E-03 | FFA | 0.43 | 1.62E-01 | |||
| 2hIns | 0.33 | 2.11E-02 | Glu | 0.63 | 9.22E-03 | Glu | 0.74 | 6.22E-03 | |||
| HOMA-IR | 0.37 | 8.73E-03 | ALT | 0.76 | 6.51E-04 | ALT | 0.78 | 2.83E-03 | |||
| HOMA-β | 0.17 | 2.53E-01 | AST | 0.51 | 4.59E-02 | AST | 0.47 | 1.21E-01 | |||
Homeostasis model assessment-insulin resistance (HOMA-IR) is calculated to reflect insulin resistance by the formula: [FPG (mM) × FIns (μU/ml)]/22.5. HOMA-β is calculated to assess insulin sensitivity by the formula: [20 × FIns (μU/ml)]%/[FPG (mM) −3.5]. Values of P < 0.05 are underlined. γ-GGT, γ-glutamyltranspeptidase; 2hIns, insulin level at 2 h; 2hPG, 2 h postprandial plasma glucose; ALT, alanine aminotransferase; FPG, fasting plasma glucose; Glu, glucose; HDL-C, HDL cholesterol; LDL-C, LDL choloesterol; VAT, visceral adipose tissue.